Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Curtius Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110128288B reveals a safe cyanide-free route for amino-substituted cyclopentane derivatives, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Novel preparation method for Raltitrexed degradation impurity ensures high purity and supply stability for pharmaceutical quality research and regulatory compliance.